NEW DELHI: Facing mounting scrutiny over drug safety lapses, India is preparing an overhaul of its pharmaceutical licensing framework by introducing a separate wholesale licensing regime for bulk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback